The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 06, 2022

Filed:

May. 08, 2020
Applicants:

Creighton University, Omaha, NE (US);

Nutech Ventures, Lincoln, NE (US);

Inventors:

Laura Hansen, Bellevue, NE (US);

Sandor Lovas, Omaha, NE (US);

Nicholas Palermo, Omaha, NE (US);

Assignees:

CREIGHTON UNIVERSITY, Omaha, NE (US);

NUTECH VENTURES, Lincoln, NE (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/10 (2006.01); A61K 38/08 (2019.01); A61K 38/00 (2006.01); A61K 9/06 (2006.01); A61P 35/00 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 5/10 (2006.01); C07K 14/00 (2006.01); C07K 5/117 (2006.01); A61K 9/107 (2006.01);
U.S. Cl.
CPC ...
C07K 5/1024 (2013.01); A61K 9/06 (2013.01); A61K 9/107 (2013.01); A61P 35/00 (2018.01); C07K 7/08 (2013.01); A61K 38/00 (2013.01);
Abstract

Systems and methods for treatment of squamous cell carcinoma or other cancer utilizing targeting peptides are described. The targeting peptides interact with SCC cells or other cancerous cells to block or interfere with 14-3-3ε heterodimerization or CDC25A binding to 14-3-3ε. A peptide composition embodiment includes, but is not limited to, at least one of a first targeting peptide comprising a structure of Trp-Tyr-Trp-Lys-NH(SEQ ID NO: 1), a second targeting peptide comprising a structure of phospho-Ser178; Ac-Thr-Gln-Arg-Gln-Asn-Ser-(PO)-Ala-Pro-Arg-Met-Leu-Ser-Ser-Asn-NH(SEQ ID NO: 2), and a third targeting peptide comprising a structure of phospho-Thr507 residue; Ac-Arg-Thr-Lys-Ser-Arg-Thr(PO)-Trp-Ala-Gly-Glu-Lys-Ser-Lys-Arg-NH(SEQ ID NO: 3).


Find Patent Forward Citations

Loading…